COMMUNIQUÉS West-GlobeNewswire

New Center for Kinesio Taping Methods opens at the University of New Mexico
27/09/2017
Albuquerque, New Mexico, Sept. 27, 2017 (GLOBE NEWSWIRE) -- On Tuesday September 26, 2017, the University of New Mexico School of Medicine Department of Neurosurgery and Kinesio began their Educational Collaborative [...]
The Finnish Financial Supervisory Authority approved Terveystalo Plc's Finnish language prospectus
27/09/2017
TERVEYSTALO PLC September 27, 2017 at 19:00 pm EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF [...]
Crown Bioscience Names Laurie Heilmann Chief Business Officer; Executive Leader Brings Expertise in Global Strategy and Commercial Leadership to the Role
27/09/2017
SANTA CLARA, Calif., Sept. 27, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company [...]
Inivata: Addario Lung Cancer Medical Research Institute and Inivata Announce Major Study of ctDNA Analysis in Early Stage Lung Cancer
27/09/2017
Addario Lung Cancer Medical Research Institute and Inivata Announce Major Study of ctDNA Analysis in Early Stage Lung Cancer InVision(TM) ctDNA liquid biopsy platform to be used to inform therapy following surgery of [...]
Terveystalo announces a fixed subscription price for its contemplated initial public offering and further information on the listing of its shares on the Official List of Nasdaq Helsinki Ltd
27/09/2017
TERVEYSTALO PLC September 27, 2017 at 11:30 am EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF [...]
Ossur Hf : Össur Capital Markets Day 27 September 2017 presentation material
27/09/2017
Enclosed is the presentation material ahead of Össur's Capital Markets Day 2017 which is held today from 8:30 - 13:00 CET in Copenhagen. Össur Capital Markets Day 27 September 2017 This announcement is distributed by [...]
Herantis Pharma has initiated patient recruitment and consented first patient in CDNF study in Parkinson's disease
27/09/2017
Herantis Pharma has initiated patient recruitment and consented first patient in CDNF study in Parkinson's disease Herantis Pharma Plc Company release 27 Sep 2017 at 9:00 am Herantis Pharma Plc ("Herantis") has [...]
Verona Pharma Reports Positive Top-Line Data from U.S. Pharmacokinetic Trial Demonstrating Nebulized RPL554 Delivers Optimal Clinical Dose to Patients
27/09/2017
Earlier than expected results demonstrate absorption occurs primarily in the lungs following inhaled administration LONDON, Sept. 27, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma [...]
Galapagos and MorphoSys report first promising signs of clinical activity in a Phase 1 study with IL-17C antibody MOR106 in atopic dermatitis patients
27/09/2017
Generally well-tolerated with no clinically relevant safety signals in Phase 1 study At the highest dose level, 5 out of 6 patients (83%) reached an improvement of at least 50% in atopic dermatitis symptoms (EASI-50) by [...]
VIFOR PHARMA EXPANDS EXCLUSIVE LICENSE AGREEMENT FOR THE COMMERCIALISATION OF MIRCERA® IN THE US
27/09/2017
PRESS RELEASE This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, [...]
Communiqué : Le projet de rapprochement entre Essilor et Luxottica se poursuit
26/09/2017
Le projet de rapprochement entre Essilor et Luxottica se poursuit Version PDF du communiqué Charenton-le-Pont, France et Milan, Italie (le 26 septembre 2017) - Essilor et Luxottica confirment que la Commission [...]
New Release: Further progress in the proposed combination between Essilor and Luxottica
26/09/2017
Further progress in the proposed combination between Essilor and Luxottica PDF Version of the news release Charenton-le-Pont, France and Milan, Italy, September 26, 2017 - Essilor and Luxottica today confirm that the [...]
Change in Nexstim Plc's Management Team
26/09/2017
Company announcement, Helsinki, 26 September 2017 at 7:00 pm Change in Nexstim Plc's Management Team Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical technology company developing and marketing [...]
GUERBET : 2017 half-year results
26/09/2017
2017 half-year results > Satisfactory activity growth > Ebitda level above 15% Villepinte, September 26, 2017 - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging [...]
GUERBET : résultats semestriels 2017
26/09/2017
Résultats semestriels 2017 > Progression satisfaisante de l'activité > Un niveau d'Ebitda supérieur à 15% Villepinte, le 26 septembre 2017 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de [...]
Mérieux Développement announces the completion of a Series B financing into PhysioAssist, to commercialize SimeoxTM as the new standard for airway clearance in Europe and internationally
26/09/2017
Press Release Fundraising - Medical Device - Cystic Fibrosis / COPD Mérieux Développement announces the completion of a Series B financing into PhysioAssist, to commercialize Simeox TM as the new standard for airway [...]
PhysioAssist raises 6 million euros in a Series B financing, to commercialize SimeoxTM as the new standard for airway clearance in Europe and internationally
26/09/2017
Press Release Fundraising - Medical Device - Cystic Fibrosis / COPD PhysioAssist raises 6 million euros in a Series B financing, to commercialize Simeox TM as the new standard for airway clearance in Europe and [...]
Auris Medical Provides Board of Directors Update
26/09/2017
Zug, Switzerland, September 26, 2017 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, announced today [...]
AroCell AB: AroCell Research Poster on TK1 / TK 210 ELISA in Prostate Cancer has been accepted for presentation at the UK National Cancer Research Institute (NCRI) Annual Meeting November 2017
26/09/2017
AroCell AB (publ) announces today that a research poster submitted by Jagarlamudi K.K. et al. entitled" AroCell TK 210 ELISA may complement pro PSA and the prostate health index in differentiating non-cancerous from [...]

Pages